Sabra Health Care REIT, Inc. (SBRA) is a leading company in the real estate investment sector, particularly specializing in healthcare-related properties. The company is structured as a Real Estate Investment Trust (REIT), which means it primarily owns and operates a portfolio of real estate properties and mortgages. Sabra's primary focus is on providing investment opportunities in the field of skilled nursing/transitional care facilities and assisted living centers.
Founded in 2010, Sabra Health Care REIT is headquartered in Irvine, California and is publicly traded on NASDAQ under the ticker symbol SBRA. Their portfolio, as of 2021, comprises over 400 properties spread across the United States and Canada.
Sabra aims to enhance the quality of patient care by partnering with strong, caring, and successful providers in the healthcare industry. They work towards producing significant, steady, and rewarding returns for their investors while providing quality patient care in their facilities.
Sabra's strategy has often been to partner with operators who align with their mission and in industries where they have extensive expertise. While majority of the properties in their portfolio are leased to long-term tenants, they occasionally operate the facilities for a short time immediately after acquisition to ensure a smooth transition and the highest quality patient care. It's worth mentioning that where possible, Sabra has made a stride towards enhancing the level of service and care provided in each facility by implementing innovative care models and strong management techniques.
Sabra Health Care REIT's commitment to generate value and provide rewards for their investors has made them a prominent player in the healthcare REIT sector. Their commitment to patient care, along with their strategic partnerships and innovative business model, greatly reflects on their strong financial performances throughout the years, granting the company a competitive advantage in the market.
Continually growing, Sabra is a company that's on the rise in the healthcare and real estate investment market. Led by an experienced executive team with substantial industry knowledge, the company strives to exceed the expectations of their stakeholders through a blend of strategic acquisitions, meticulous management of properties, and rigorous evaluation of potential investments. As Sabra continues to expand its footprint in the healthcare real estate investment world, it persistently upholds its commitment to quality patient care and shareholder value.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
Sabra Healthcare REIT (NASDAQ:SBRA) has received a "Moderate Buy" rating from Wall Street brokerages, with seven out of fourteen analysts recommending a buy and the remaining seven suggesting a hold. The average 12-month price target is $22.23, exceeding its recent price of $19.77. Despite missing earnings expectations with a reported loss of ($0.10) per share, the company's quarterly revenue increased by 24.7% year-over-year to $230.11 million, and it maintains a high institutional ownership of 99.40%.
Squarepoint Ops LLC significantly reduced its holdings in Sabra Healthcare REIT (SBRA) by 93.6% in the second quarter, selling 157,633 shares and retaining 10,868 shares. Despite missing EPS estimates, Sabra's revenue rose 24.7% year-over-year, and the company maintains a quarterly dividend of $0.30 per share, reflecting a 6.1% annualized yield. Institutional investors hold 99.4% of SBRA, with analysts giving it a "Moderate Buy" rating and an average price target of $22.23.
NewEdge Advisors LLC significantly increased its stake in Sabra Healthcare REIT (NASDAQ:SBRA) by 261.2% in the second quarter, bringing its total holdings to 71,128 shares valued at $1.39 million. Institutional investors collectively own 99.4% of the company, which holds a "Moderate Buy" consensus rating from analysts with an average price target of $22.23. Despite missing EPS estimates, Sabra reported a 24.7% year-over-year revenue increase and recently paid a quarterly dividend of $0.30, yielding 6.1% annually.
Sabra Healthcare REIT (NASDAQ:SBRA) saw its shares briefly exceed its 200-day moving average, reaching $20.42 before closing at $20.15. The company reported a quarterly earnings miss but revenue beat expectations, and it maintains a $0.30 quarterly dividend despite a high payout ratio. Analysts have a "Moderate Buy" rating, and CEO Richard Matros recently sold a significant block of shares.
Huntington has initiated coverage on Sabra Healthcare REIT (NASDAQ:SBRA) with an "outperform" rating and a $23 price target, signaling a potential 10.6% upside. The company currently holds a consensus "Moderate Buy" rating from analysts, with an average price target of $22.23. Despite reporting mixed quarterly results—revenue exceeding estimates but adjusted EPS missing—and CEO Richard Matros selling a significant number of shares, the overall analyst sentiment remains positive.
Engineers Gate Manager LP significantly reduced its stake in Sabra Healthcare REIT (NASDAQ:SBRA) by 55.5% during the second quarter, selling 1.31 million shares and retaining 1.05 million shares valued at $20.5 million. Despite this, institutional investors still hold 99.4% of SBRA's outstanding stock. Sabra reported quarterly revenue exceeding estimates but missed EPS forecasts, while maintaining a quarterly dividend of $0.30, representing a 5.8% yield.
Richard K. Matros, CEO of Sabra Health Care REIT, Inc., sold 200,000 shares of company stock for approximately $4.17 million on September 8, 2026, pursuant to a pre-arranged trading plan. This transaction occurred amidst mixed financial results for Sabra Health Care in Q2 2026, where revenue beat expectations but the company reported an adjusted net loss due to a loan-loss provision. Despite this, management reaffirmed its full-year guidance, and Raymond James upgraded the stock to Market Perform.
Sabra Healthcare REIT (NASDAQ:SBRA) CEO Richard Matros sold 200,000 shares worth approximately $4.17 million, reducing his ownership by 10.77% to 1.66 million shares. The transaction, executed under a Rule 10b5-1 plan, occurred as the company reported a quarterly loss despite revenue growth. Analysts currently maintain a consensus "Hold" rating for SBRA with a price target of $22.17.
Virginia Retirement Systems acquired 309,853 shares of Sabra Healthcare REIT (NASDAQ:SBRA) valued at approximately $6.05 million during the second quarter, bringing institutional ownership in the company to 99.40%. Despite reporting a 24.7% year-over-year revenue increase to $230.11 million, Sabra missed EPS estimates with a negative $0.10. The company maintains a quarterly dividend of $0.30 per share and analysts currently rate the stock as a "Hold" with an average price target of $22.17.